Racial and Ethnic Disparities in Adherence to Glaucoma Follow-up Visits in a County Hospital Population | Glaucoma | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.238.77. Please contact the publisher to request reinstatement.
1.
Giangiacomo AC. The epidemiology of glaucoma. In: Grehn F, Stamper R, eds. Glaucoma. Berlin, Germany: Springer; 2009:13-21
2.
Kass MA, Heuer DK, Higginbotham EJ,  et al.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.  Arch Opthalmol. 2002;120(6):701-730Google ScholarCrossref
3.
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E.Early Manifest Glaucoma Trial Group.  Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial.  Arch Ophthalmol. 2003;121(1):48-5612523884PubMedGoogle ScholarCrossref
4.
Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z.EMGT Group.  Predictors of long-term progression in the Early Manifest Glaucoma Trial.  Ophthalmology. 2007;114(11):1965-197217628686PubMedGoogle ScholarCrossref
5.
Epstein DL, Krug JH Jr, Hertzmark E, Remis LL, Edelstein DJ. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects.  Ophthalmology. 1989;96(10):1460-14672685707PubMedGoogle ScholarCrossref
6.
Kass MA. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.  Trans Am Ophthalmol Soc. 1989;87:598-6182562546PubMedGoogle Scholar
7.
Schulzer M, Drance SM, Douglas GR. A comparison of treated and untreated glaucoma suspects.  Ophthalmology. 1991;98(3):301-3072023749PubMedGoogle ScholarCrossref
8.
DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research.  Med Care. 2004;42(3):200-20915076819PubMedGoogle ScholarCrossref
9.
Friedman DS, Hahn SR, Quigley HA,  et al.  Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.  Ophthalmology. 2009;116(12):2277-2285Google ScholarCrossref
10.
American Academy of Ophthalmology Glaucoma Panel.  Preferred Practice Patterns: Primary Open-Angle Glaucoma, Primary Open-Angle Glaucoma Suspect, and Primary Angel Closure. San Francisco, CA: American Academy of Ophthalmology; 2005
11.
Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.  Ophthalmology. 1998;105(11):2105-21119818613PubMedGoogle ScholarCrossref
12.
Lee BW, Sathyan P, John RK, Singh K, Robin AL. Predictors of and barriers associated with poor follow-up in patients with glaucoma in South India.  Arch Ophthalmol. 2008;126(10):1448-145418852425PubMedGoogle ScholarCrossref
13.
Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.  Arch Ophthalmol. 2001;119(12):1819-182611735794PubMedGoogle ScholarCrossref
14.
Shimmyo M, Ross AJ, Moy A, Mostafavi R. Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African Americans.  Am J Ophthalmol. 2003;136(4):603-61314516799PubMedGoogle ScholarCrossref
15.
Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey.  JAMA. 1991;266(3):369-3742056646PubMedGoogle ScholarCrossref
16.
Kim E, Varma R. Glaucoma in Latinos/Hispanics.  Curr Opin Ophthalmol. 2009;21(2):100-10519077825PubMedGoogle ScholarCrossref
17.
Varma R, Ying-Lai M, Francis BA,  et al; Los Angeles Latino Eye Study Group.  Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study.  Ophthalmology. 2004;111(8):1439-144815288969PubMedGoogle ScholarCrossref
18.
Martin MJ, Sommer A, Gold EB, Diamond EL. Race and primary open-angle glaucoma.  Am J Ophthalmol. 1985;99(4):383-3873985075PubMedGoogle ScholarCrossref
19.
Sommer A, Tielsch JM, Katz J,  et al.  Racial differences in the cause-specific prevalence of blindness in east Baltimore.  N Engl J Med. 1991;325(20):1412-14171922252PubMedGoogle ScholarCrossref
20.
Wormald RP, Basauri E, Wright LA, Evans JR. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London.  Eye (Lond). 1994;8(pt 3):315-3207958037PubMedGoogle ScholarCrossref
21.
Gwira JA, Vistamehr S, Shelsta H,  et al.  Factors associated with failure to follow up after glaucoma screening: a study in an African American population.  Ophthalmology. 2006;113(8):1315-131916769119PubMedGoogle ScholarCrossref
22.
Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year.  Br J Cancer. 1992;65(6):922-9261616865PubMedGoogle ScholarCrossref
23.
Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival.  Am J Public Health. 2004;94(12):2104-211115569961PubMedGoogle ScholarCrossref
24.
Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun EE, Warnecke RB. Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients.  Cancer Epidemiol Biomarkers Prev. 2010;19(3):640-64720200436PubMedGoogle ScholarCrossref
25.
Institute of Medicine.  The healthcare environment and its relation to disparities. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2003:29-80
26.
Institute of Medicine.  Assessing potential sources of racial and ethnic disparities in care: patient- and system-level factors. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2003:125-159
27.
Institute of Medicine.  Assessing potential sources of racial and ethnic disparities in care in the clinical encounter. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2003:160-179
28.
US Department of Health & Human Services.  National Healthcare Disparities Report. Washington, DC: US Dept of Health and Human Services; 2003
Clinical Sciences
July 2011

Racial and Ethnic Disparities in Adherence to Glaucoma Follow-up Visits in a County Hospital Population

Author Affiliations

Author Affiliations: Departments of Ophthalmology, Stanford University, Stanford, California (Drs Murakami, Lee, and Singh and Mr Duncan), University of California, San Francisco (Drs Kao and Lin), and National Taiwan University Hospital, Taipei, Taiwan (Dr Huang).

Arch Ophthalmol. 2011;129(7):872-878. doi:10.1001/archophthalmol.2011.163
Abstract

Objectives To identify predictors of inconsistent attendance at glaucoma follow-up visits in a county hospital population.

Methods Prospective recruitment from August 1, 2008, through January 31, 2009, of 152 individuals with glaucoma, with 1-to-1 matching of patients (those with inconsistent follow-up) and controls (those with consistent follow-up). Data were collected via oral questionnaire. Survey results were correlated with attendance at follow-up examinations, using the t test, χ2 test, and multivariate stepwise logistic regression analysis to calculate the odds ratios (ORs) and 95% confidence intervals.

Results After adjusting for covariates in the logistic regression analysis, factors independently associated with inconsistent follow-up included black race (adjusted OR, 7.16; 95% confidence interval, 1.64-31.24), Latino ethnicity (adjusted OR, 4.77; 1.12-20.29), unfamiliarity with necessary treatment duration (adjusted OR, 3.54; 1.26-9.94), lack of knowledge of the permanency of glaucoma-induced vision loss (adjusted OR, 3.09; 1.18-8.04), and perception that it is not important to attend all follow-up visits (adjusted OR, 3.54; 1.26-9.94).

Conclusions Demographic factors, including race and ethnicity, may directly or indirectly affect adherence to recommended glaucoma follow-up visits. Lack of information regarding irreversible vision loss from glaucoma, need for lifelong treatment, and lack of visual symptoms may be significant barriers to follow-up in this population. Targeted glaucoma education by physicians may improve follow-up, thereby decreasing the morbidity associated with glaucomatous disease.

×